Insufficient scRNA-seq data for expression of H2BC15 at single-cell level.
Insufficient scRNA-seq data for expression of H2BC15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 107.70 | 245 / 245 | 90% | 2.25 | 452 / 502 |
ovary | 100% | 98.52 | 180 / 180 | 66% | 1.68 | 283 / 430 |
breast | 96% | 49.77 | 439 / 459 | 67% | 1.88 | 744 / 1118 |
adrenal gland | 100% | 89.72 | 258 / 258 | 52% | 0.99 | 120 / 230 |
skin | 96% | 43.63 | 1744 / 1809 | 54% | 1.41 | 257 / 472 |
esophagus | 94% | 28.93 | 1356 / 1445 | 54% | 1.28 | 99 / 183 |
thymus | 100% | 74.54 | 653 / 653 | 43% | 0.73 | 262 / 605 |
lung | 99% | 70.41 | 575 / 578 | 44% | 1.01 | 506 / 1155 |
kidney | 100% | 51.91 | 89 / 89 | 43% | 0.72 | 384 / 901 |
uterus | 99% | 66.02 | 169 / 170 | 40% | 0.86 | 182 / 459 |
liver | 99% | 70.55 | 224 / 226 | 38% | 0.85 | 156 / 406 |
stomach | 94% | 36.14 | 337 / 359 | 39% | 0.88 | 112 / 286 |
bladder | 100% | 32.19 | 21 / 21 | 31% | 1.15 | 158 / 504 |
brain | 93% | 65.87 | 2467 / 2642 | 31% | 0.58 | 221 / 705 |
pancreas | 100% | 80.01 | 327 / 328 | 22% | 0.44 | 40 / 178 |
intestine | 94% | 38.17 | 905 / 966 | 28% | 0.72 | 145 / 527 |
spleen | 100% | 71.80 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.16 | 1 / 1 |
blood vessel | 99% | 61.34 | 1327 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 48.67 | 793 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 71.67 | 908 / 929 | 0% | 0 | 0 / 0 |
adipose | 94% | 35.64 | 1137 / 1204 | 0% | 0 | 0 / 0 |
heart | 94% | 53.19 | 809 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 39% | 0.76 | 31 / 80 |
lymph node | 0% | 0 | 0 / 0 | 34% | 0.55 | 10 / 29 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.29 | 8 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006334 | Biological process | nucleosome assembly |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000786 | Cellular component | nucleosome |
GO_0005634 | Cellular component | nucleus |
GO_0030527 | Molecular function | structural constituent of chromatin |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0003677 | Molecular function | DNA binding |
Gene name | H2BC15 |
Protein name | Histone H2B type 1-N (Histone H2B.d) (H2B/d) Histone H2B |
Synonyms | hCG_1743059 H2BFD HIST1H2BN |
Description | FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. . |
Accessions | U3KQK0 Q99877 ENST00000612898.2 ENST00000449538.3 ENST00000606613.1 |